Bepotastine besilate
Showing 26 - 32 of 32
Allergic Rhinitis, Urticaria, Pruritus Trial in Seoul (Test-Bepotastine salicylate 9.64 mg, Reference-bepotastine besilate 10
Completed
- Allergic Rhinitis
- +2 more
- Test-Bepotastine salicylate 9.64 mg
- Reference-bepotastine besilate 10 mg
-
Seoul, Korea, Republic ofDept. of Clinical Pharmacology & Toxicology, Anam Hospital
Jul 11, 2013
Allergic Conjunctivitis Trial in Irvine (Bepreve (bepotastine besilate ophthalmic solution) 1.5%, comparator, Bepotastine
Completed
- Allergic Conjunctivitis
- Bepreve (bepotastine besilate ophthalmic solution) 1.5%
- +2 more
-
Irvine, CaliforniaISTA Pharmaceuticals, Inc.
Feb 4, 2013
Conjunctivitis, Allergic Trial in Irvine (Bepreve, Placebo, Bepotastine Besilate)
Completed
- Conjunctivitis, Allergic
- Bepreve
- +2 more
-
Irvine, CaliforniaISTA Pharmaceuticals, Inc.
Feb 13, 2013
Histamine Responsive Allergy Patients Trial in Fort Worth (Bepreve, Refresh Tears)
Completed
- Histamine Responsive Allergy Patients
- Bepreve
- Refresh Tears
-
Fort Worth, TexasNorth Texas Institute for Clinical Trials
Jul 7, 2010
Hypertension, Cardiovascular Diseases Trial in Kyoto (Candesartan cilexetil)
Unknown status
- Hypertension
- Cardiovascular Diseases
- Candesartan cilexetil
-
Kyoto, Yoshidakonoe-cho, Sakyo-ku, Kyoto, JapanKyoto University
Aug 8, 2005